Healthcare Sales & Marketing Network News: aspirin

Searching News Database: aspirin

HSMN NewsFeed - 25 Sep 2024
Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF(R) Vial Access Needle ("VAN")
Devices Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 26 Mar 2024
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS(R)
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 8 Sep 2023
IceCure Medical to Join Hands-On Cryoablation Session with ProSense and Host Symposium Led by Renowned Doctors at the CIRCE 2023 Annual Congress
Devices

HSMN NewsFeed - 15 Aug 2023
Vertos Medical Promotes Two Senior Leaders to Newly Created C-Suite Roles
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 6 Sep 2022
Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX(TM) LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option
Devices Interventional Cardiology FDA

HSMN NewsFeed - 22 Feb 2022
Vertos Medical Announces Results Showing Meaningful Mobility Improvement Following mild(R) Procedure
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 8 Feb 2022
FDA Approves JUVÉDERM(R) VOLBELLA(R) XC for Undereye Hollows
Devices Dermatology FDA

HSMN NewsFeed - 1 Jul 2021
Heron Therapeutics Announces U.S. Commercial Launch and Availability of ZYNRELEF(TM) for the Management of Postoperative Pain for up to 72 Hours
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 30 Jun 2021
Abbott's XIENCE Stent Receives FDA Approval for Shortest Blood Thinner Course for High Bleeding Risk Patients
Devices Interventional Cardiology FDA

HSMN NewsFeed - 13 May 2021
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF(TM) (HTX-011) for the Management of Postoperative Pain for up to 72 Hours
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Feb 2021
Galderma Receives FDA Approval for Restylane(R) Defyne for Chin Augmentation
Devices Dermatology FDA

HSMN NewsFeed - 8 Dec 2020
Vertos Medical Announces ASC Reimbursement Increase for the mild(R) Procedure
Devices Orthopaedic Neurosurgery Reimbursement

HSMN NewsFeed - 22 Jun 2020
FDA Accepts Supplemental Biologics License Application (sBLA) for BOTOX(R) (onabotulinumtoxinA) for the Treatment of Pediatric Patients with Neurogenic Detrusor Overactivity
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 5 May 2020
Galderma Receives FDA Approval For Restylane(R) Kysse, A New Hyaluronic Acid (HA) Filler Specifically Designed And Indicated To Add Fullness To The Lips And Help Smooth The Wrinkles Above The Mouth
Devices Dermatology FDA

HSMN NewsFeed - 27 Apr 2020
Cytosorbents Appoints Dr. Efthymios N. Deliargyris, M.D., As Chief Medical Officer
Devices Personnel

HSMN NewsFeed - 29 Jan 2020
CytoSorb(R) is Approved and Available for the Removal of Ticagrelor, a Leading Anti-Platelet Drug, During Cardiopulmonary Bypass in the E.U.
Devices Regulatory Product Launch

HSMN NewsFeed - 2 Dec 2019
Cumberland Pharmaceuticals Receives FDA Approval for RediTrex(TM) Product Line
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Nov 2019
Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
Biopharmaceuticals Dermatology

HSMN NewsFeed - 30 Oct 2019
Biogen and Alkermes Announce FDA Approval of VUMERITY(TM) (diroximel fumarate) for Multiple Sclerosis
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 24 Oct 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Lower Limb Spasticity, Excluding Spasticity Caused by Cerebral Palsy
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Oct 2019
FDA Grants Ofev(R) Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a Progressive Phenotype
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Sep 2019
Allergan Receives FDA Approval of Juvéderm VOLUMA(R) XC For Mid-Face Injection Via Cannula
Biopharmaceuticals Devices Dermatology FDA

HSMN NewsFeed - 21 Jun 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Jun 2019
Lannett Launches Aspirin And Extended-Release Dipyridamole Capsules
Biopharmaceuticals Generics

HSMN NewsFeed - 27 Mar 2019
Lannett Receives FDA Approval For Aspirin And Extended-Release Dipyridamole Capsules, 25 mg/200 mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 18 Mar 2019
Boehringer Ingelheim announces FDA and EMA regulatory submission for nintedanib in systemic sclerosis associated ILD
Biopharmaceuticals FDA Regulatory

HSMN NewsFeed - 7 Mar 2019
FDA Accepts Supplemental Biologics License Applications (sBLAs) for BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper and Lower Limb Spasticity
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Nov 2018
MabVax Therapeutics Holdings, Inc. Announces $1.0 Million Equity Purchase Agreement
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 12 Nov 2018
Lannett Enters Into Agreement With Amneal Pharmaceuticals For Levothyroxine
Biopharmaceuticals Generics Distribution

HSMN NewsFeed - 5 Nov 2018
Galderma Announces FDA Approval of Restylane(R) Lyft For Midface Injection via Cannula
Devices Dermatology FDA

HSMN NewsFeed - 1 Oct 2018
First Patient Enrolled in Vertos Medical's New MOTION Study of MILD(R) Procedure, a Minimally Invasive Treatment for Lumbar Spinal Stenosis
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 24 Sep 2018
Cumberland Pharmaceuticals Announces Senior Music Industry Executive Joins Its Board Of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Sep 2018
Vertos Medical Announces MILD(R) Procedure Long-term Safety and Efficacy Data
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 27 Aug 2018
Janssen Announces Results from MARINER and COMMANDER HF Studies
Biopharmaceuticals Cardiology

HSMN NewsFeed - 20 Aug 2018
Lannett Provides Update On Contract Renewal With Jerome Stevens Pharmaceuticals
Biopharmaceuticals Generics Licensing Distribution

HSMN NewsFeed - 13 Aug 2018
Cumberland Pharmaceuticals Appoints New Senior Executive
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 May 2018
Egalet Announces Large Regional Plan to Cover SPRIX(R) Nasal Spray
Biopharmaceuticals Reimbursement

HSMN NewsFeed - 21 May 2018
Nestlé Skin Health Announces the FDA Approval of Restylane(R) Lyft for Hands, the First and Only Hyaluronic Acid (HA) Dermal Filler for Use in the Back of Hands
Devices Dermatology FDA

HSMN NewsFeed - 7 May 2018
ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax
Biopharmaceuticals Generics Acquisitions

HSMN NewsFeed - 9 Apr 2018
Cumberland Pharmaceuticals Expands into Oncology Support
Biopharmaceuticals Oncology Licensing Distribution

HSMN NewsFeed - 30 Oct 2017
FDA Approves New 10 mg Dosing for XARELTO(R) (rivaroxaban) to Reduce the Continued Risk of Venous Thromboembolism (VTE)
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Oct 2017
Bayer Appoints Jennifer Brendel to Vice President, Head of U.S. Consumer Health Communications
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Sep 2017
Cumberland Pharmaceuticals Launches Promotion of Totect(R) in The U.S. for Emergency Oncology Intervention
Biopharmaceuticals Oncology Product Launch

HSMN NewsFeed - 21 Sep 2017
ManaMed Inc. Introduces PlasmaFlow, The World's First FDA-Approved Digital and Tubeless Deep Vein Thrombosis Prevention Device
Devices Product Launch

HSMN NewsFeed - 12 Jun 2017
Vertos Medical Secures $28 Million In Latest Round Of Funding
Devices Orthopaedic Neurosurgery Venture Capital

HSMN NewsFeed - 31 May 2017
Lilly Announces Phase 3 RANGE Urothelial Cancer Trial of CYRAMZA(R) (ramucirumab) Met Primary Endpoint, Improving Progression-Free Survival
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Mar 2017
JUVÉDERM VOLLURE(TM) XC Approved by U.S. FDA for Correction of Facial Wrinkles and Folds in Adults over the Age of 21
Devices Dermatology FDA

HSMN NewsFeed - 16 Jan 2017
Cumberland Pharmaceuticals Announces Kenneth J. Krogulski To Join Its Board Of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Dec 2016
Dipexium and PLx Pharma Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 16 Dec 2016
Antibe Therapeutics Raises $2.4 Million in First Tranche of Private Placement
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 12 Dec 2016
Galderma Announces FDA Approval of Restylane(R) Refyne and Restylane(R) Defyne Dermal Fillers for Treatment of "Laugh Lines"
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 16 Nov 2016
Cumberland Pharmaceuticals Acquires U.S. Rights to Nordic Group's Methotrexate Injection Products
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 24 Oct 2016
Efficacy of Ofev(R) (nintedanib) Reinforced in Range of Patients with IPF in New Analyses Presented at CHEST
Biopharmaceuticals

HSMN NewsFeed - 1 Sep 2016
FDA Approves New AGGRASTAT(R) Product Format
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 6 Jul 2016
Knight and Ember Expand Distribution Partnership
Biopharmaceuticals Distribution

HSMN NewsFeed - 11 May 2016
Medicure Files Application for New AGGRASTAT(R) Product Format
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 29 Mar 2016
Shire Wins Patent Trial Against Watson Concerning LIALDA(R)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 28 Mar 2016
Aralez Announces FDA Acceptance of New Drug Application for YOSPRALA(TM)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 16 Feb 2016
VIVLODEX(TM) Now Available in U.S. Pharmacies for the Management of Osteoarthritis Pain
Biopharmaceuticals Product Launch

HSMN NewsFeed - 25 Jan 2016
Piramal Critical Care and Cumberland Pharmaceuticals Announce Launch of Caldolor and Vaprisol Co-Promotion
Biopharmaceuticals Distribution Product Launch

HSMN NewsFeed - 22 Jan 2016
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Jan 2016
VIBERZI(TM) (eluxadoline) Phase III Trial Results Published in The New England Journal of Medicine
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 4 Jan 2016
PLx Pharma Appoints Natasha Giordano as CEO
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 23 Oct 2015
Iroko Pharmaceuticals Receives FDA Approval for VIVLODEX(TM) - First Low Dose SoluMatrix(R) Meloxicam for Osteoarthritis Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Oct 2015
U.S. FDA Approves JUVEDERM(R) ULTRA XC for Use in Lips
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 14 Sep 2015
POZEN Appoints James P. Tursi, M.D. Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Aug 2015
FDA Approves Taro’s Keveyis(TM) (dichlorphenamide) 50 mg Tablets for Primary Hyperkalemic and Hypokalemic Periodic Paralysis
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Jul 2015
POZEN Appoints Scott Charles Senior Vice President of Finance
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jul 2015
The Medicines Company Authorizes Generic Launch of ANGIOMAX(R) (bivalirudin)
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 1 Jun 2015
POZEN Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Dec 2014
The Medicines Company and SciClone Pharmaceuticals Establish Strategic Partnership for Two Cardiovascular Products in China
Biopharmaceuticals Cardiology Licensing

HSMN NewsFeed - 16 Sep 2014
First-In-Man Study of the COBRA PzF(TM) Coronary Stent Shows Promising Results Highlighted by Short, 30-Day Dual-Antiplatelet Therapy and Low, 3% TLR Rate
Devices Interventional Cardiology

HSMN NewsFeed - 27 Jun 2014
Eliquis(R) (apixaban) Receives CHMP Positive Opinion for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE
Biopharmaceuticals Regulatory

HSMN NewsFeed - 14 May 2014
POZEN Announces U.S. Rights for Treximet(R) to Be Acquired by Pernix Therapeutics
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 12 May 2014
FDA Approves ZONTIVITY(TM) (vorapaxar), First-in-Class PAR-1 Antagonist, for the Reduction of Thrombotic Cardiovascular Events in Patients with a History of Heart Attack or with Peripheral Arterial Disease
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 12 Mar 2014
Corgenix Board of Directors Announces Exploration of Strategic Alternatives
Diagnostics

HSMN NewsFeed - 21 Feb 2014
In a Subanalysis, Eliquis(R) (apixaban) Reduced the Risk of Stroke and Demonstrated Fewer Major Bleeding Events versus Warfarin Consistently across Age Groups, Including Older Patients with Nonvalvular Atrial Fibrillation
Biopharmaceuticals Cardiology

HSMN NewsFeed - 3 Jan 2014
Iroko’s ZORVOLEX(TM) Now Available
Biopharmaceuticals Product Launch

HSMN NewsFeed - 5 Nov 2013
First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Hot Flashes Now Available by Prescription in U.S. Pharmacies
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Oct 2013
The Medicines Company's EUROMAX Trial of Angiox(R) (Bivalirudin) in Heart Attack Meets All Prespecified Endpoints
Biopharmaceuticals Cardiology

HSMN NewsFeed - 23 Oct 2013
FDA Approves JUVÉDERM VOLUMA(TM) XC
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 9 Oct 2013
First Patient Enrolled in Phase III Trial Evaluating The Medicines Company's Angiomax(R) (Bivalirudin) in Patients Undergoing Peripheral Endovascular Procedures
Biopharmaceuticals Interventional

HSMN NewsFeed - 3 Sep 2013
Subanalysis of Phase III ARISTOTLE Trial of Eliquis(R) (apixaban) Demonstrated Consistent Results Versus Warfarin in Patients with Nonvalvular Atrial Fibrillation with or without Valvular Heart Disease
Biopharmaceuticals Cardiology

HSMN NewsFeed - 30 Aug 2013
ITC Acquires Accumetrics to Form Leading POC Cardiovascular Diagnostics Business
Diagnostics Cardiology Mergers & Acquisitions

HSMN NewsFeed - 22 Aug 2013
Horizon Pharma Announces Settlement of DUEXIS(R) Patent Litigation With Par Pharmaceutical
Biopharmaceuticals Generics Litigation Licensing

HSMN NewsFeed - 31 Jul 2013
New Sub-Analysis of PLATO ACS Study Suggests Patient Types and Stent Types Had No Impact on Findings of Reduced Rate of Stent Thrombosis With BRILINTA (ticagrelor)
Biopharmaceuticals Devices Interventional Cardiology

HSMN NewsFeed - 7 May 2013
Corgenix Gains CE Mark for ReLASV(R) Antigen Rapid Test for Diagnosis of Lassa Fever
Diagnostics Regulatory

HSMN NewsFeed - 21 Feb 2013
Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection To Sandor Medicaids Pvt. Ltd. For Commercialization In India
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 14 Nov 2012
Largest Prospective Study Shows IVUS-Guided Stent Placement Improves Patient Outcomes with Current Generation of Stents
Devices Interventional Cardiology

HSMN NewsFeed - 23 Oct 2012
Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami
Devices Interventional Cardiology

HSMN NewsFeed - 30 Aug 2012
Teva Announces FDA Grants Approval for Tbo-filgrastim for the Treatment of Chemotherapy-Induced Neutropenia
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 28 Aug 2012
Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
Biopharmaceuticals Cardiology

HSMN NewsFeed - 15 May 2012
Abbott's XIENCE PRIME(TM) and XIENCE V(R) Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 9 May 2012
Janssen Research & Development Submits Supplemental New Drug Application to U.S. FDA for XARELTO(R) (rivaroxaban) to Reduce the Risk of Stent Thrombosis in Patients with Acute Coronary Syndrome
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 22 Mar 2012
POZEN Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of PA32540
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 3 Jan 2012
New Study Links Daily Aspirin Use to Increased Risk of Age-Related Macular Degeneration
Biopharmaceuticals Cardiology Ophthalmology

HSMN NewsFeed - 5 Dec 2011
Data Published in EuroIntervention Indicate that OrbusNeich's Genous(TM) Stent Is Safe with Very Short-Term Dual Antiplatelet Therapy
Devices Interventional Cardiology

HSMN NewsFeed - 25 Oct 2011
Lilly Announces Withdrawal of Xigris(R) Following Recent Clinical Trial Results
Biopharmaceuticals

HSMN NewsFeed - 12 Jul 2011
POZEN Announces Tomas S. Bocanegra, M.D. as Head of Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 May 2011
Caldolor(R) Clinical Study in Hospitalized Burn Patients Published in Journal of Burn Care & Research
Biopharmaceuticals

HSMN NewsFeed - 11 May 2011
Accumetrics Signs National Distribution Agreement with Cardinal Health
Diagnostics Personalized Medicine Cardiology Distribution

HSMN NewsFeed - 25 Apr 2011
Horizon Pharma Announces FDA Approval of DUEXIS(R) (ibuprofen/famotidine) for the Relief of the Signs and Symptoms of Rheumatoid Arthritis and Osteoarthritis and to Decrease the Risk of Developing Upper Gastrointestinal Ulcers
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Apr 2011
Preliminary Injunction Ordered in POZEN Treximet Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 18 Mar 2011
PharmStar Pharmaceuticals Appoints Howard Phykitt as Chairman and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Mar 2011
Quest Diagnostics to Acquire Celera, Strengthening Position as World's Leading Innovator in Molecular Diagnostics and Development
Diagnostics Personalized Medicine Mergers & Acquisitions

HSMN NewsFeed - 9 Mar 2011
2011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery
Diagnostics Biopharmaceuticals Surgery Cardiology

HSMN NewsFeed - 22 Feb 2011
Published Data From e-HEALING Registry Demonstrate Good Clinical Outcomes With Low Incidence of Repeat Revascularization and Stent Thrombosis for OrbusNeich's Genous Stent
Devices Interventional Cardiology

HSMN NewsFeed - 22 Feb 2011
Erica L. Mann, Former Pfizer Executive, Appointed New President of Bayer HealthCare's Global Consumer Care Division
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Feb 2011
POZEN Announces Addition to Commercial Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Feb 2011
Pervasis Receives FDA Fast Track Status for Vascugel(R) to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis
Biopharmaceuticals Interventional FDA

HSMN NewsFeed - 27 Jan 2011
Newly Published Data Demonstrates Caldolor(R) Significantly Reduces Pain and Morphine Use in Post-Operative Patients
Biopharmaceuticals Pain Management Surgery

HSMN NewsFeed - 26 Jan 2011
Bristol-Myers Squibb and sanofi-aventis Announce U.S. FDA Decision to Grant Pediatric Exclusivity For PLAVIX
Biopharmaceuticals Cardiology Generics FDA

HSMN NewsFeed - 24 Jan 2011
Clinical Data, Inc. Announces FDA Approval of Viibryd(TM) (vilazodone HCl) for Major Depressive Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Jan 2011
Safety and Efficacy of OrbusNeich's Genous Stent Demonstrated in High-Risk Patients with Known Contraindications for Dual Antiplatelet Therapy
Devices Interventional Cardiology

HSMN NewsFeed - 7 Jan 2011
JPB Capital Partners and Ilex Consumer Products Group Acquire ST. JOSEPH'S(R) ASPIRIN Brand From Johnson & Johnson
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 6 Jan 2011
Corgenix Announces 28 Percent Increase in Reimbursement Rate for AspirinWorks(R) Test
Diagnostics Reimbursement Personalized Medicine

HSMN NewsFeed - 16 Nov 2010
Mortality Data Presented for Patients Treated with Effient(R) Who Underwent Isolated Coronary Artery Bypass Surgery
Biopharmaceuticals Cardiology Surgery

HSMN NewsFeed - 16 Nov 2010
GRAVITAS Trial Shows That a Uniform Treatment Strategy of Doubling the Standard Dose of Plavix Does Not Improve Outcomes Post-PCI
Diagnostics Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 27 Oct 2010
PerkinElmer Releases DELFIA(R) Xpress PlGF Assay for Early Detection of Pre-eclampsia in Pregnant Women
Diagnostics

HSMN NewsFeed - 23 Sep 2010
Portola Pharmaceuticals Appoints Jean-Jacques Bienaime to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Aug 2010
Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet Need in Patients with Atrial Fibrillation
Biopharmaceuticals Cardiology

HSMN NewsFeed - 10 Aug 2010
Labopharm announces U.S. launch of OLEPTRO(TM) for treatment of major depressive disorder in adults
Biopharmaceuticals

HSMN NewsFeed - 25 May 2010
St. Jude Medical Enrolls First Patient in FAME II Clinical Trial to Study Use of Fractional Flow Reserve Technology in Patients With Stable Coronary Artery Disease
Devices Interventional Cardiology

HSMN NewsFeed - 17 May 2010
ROXRO Announces FDA Approval of SPRIX(TM)
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 3 May 2010
FDA Approved VIMOVO(TM) for Arthritis Patients at Risk of Developing NSAID-Associated Gastric Ulcers
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 15 Mar 2010
Inadequate Response to Clopidogrel Leads to Higher Incidence of Major Adverse Cardiac Events in Patients Who have Undergone PCI
Biopharmaceuticals Diagnostics Cardiology

HSMN NewsFeed - 11 Mar 2010
Portola Pharmaceuticals Announces Senior Management and Board Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Feb 2010
Cymbalta(R) Significantly Reduced Chronic Low Back Pain in New Study
Biopharmaceuticals

HSMN NewsFeed - 1 Feb 2010
Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Jan 2010
Covidien and Allergan Extend Agreement to Promote LAP-BAND(R) Adjustable Gastric Banding System
Devices Surgery Distribution

HSMN NewsFeed - 5 Jan 2010
New Analysis Showed Effient(R) Cost-Effective Compared with Clopidogrel for Patients with Acute Coronary Syndromes Undergoing PCI
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 4 Jan 2010
Boston Scientific Announces Enrollment of First Patient in Post-Approval Study for TAXUS Liberte Stent
Devices Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 1 Dec 2009
The Medicines Company Receives European Approval for Angiox(R) (Bivalirudin) for Use in Heart Attack Patients Undergoing Emergency Heart Procedures
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 30 Nov 2009
FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 23 Nov 2009
Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients
Biopharmaceuticals

HSMN NewsFeed - 19 Nov 2009
AstraZeneca Submits US New Drug Application for Ticagrelor (BRILINTA(TM)), an Investigational Antiplatelet Agent
Biopharmaceuticals Cardiology

HSMN NewsFeed - 29 Oct 2009
Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
Biopharmaceuticals

HSMN NewsFeed - 24 Sep 2009
Ticagrelor Reduced Cardiovascular Deaths and Heart Attacks in ACS Patients Undergoing Heart Procedures: New Data from PLATO Trial
Biopharmaceuticals Cardiology

HSMN NewsFeed - 24 Sep 2009
Portola Pharmaceuticals Announces Promotions of Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Sep 2009
New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta(R)
Biopharmaceuticals

HSMN NewsFeed - 9 Sep 2009
Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever
Biopharmaceuticals

HSMN NewsFeed - 31 Aug 2009
First Patient Enrolled in CYPRESS, a Dual Antiplatelet Therapy Trial with the CYPHER(R) Sirolimus-Eluting Coronary Stent
Devices Interventional Cardiology

HSMN NewsFeed - 30 Aug 2009
New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 13 Aug 2009
Abbott Expands XIENCE V(R) USA Trial to Enroll Patients into Landmark Dual Anti-Platelet Therapy (DAPT) Trial
Devices Interventional Cardiology

HSMN NewsFeed - 19 Jun 2009
FDA Grants The Medicines Company Pediatric Exclusivity for Angiomax(R)
Biopharmaceuticals Cardiology

HSMN NewsFeed - 17 Jun 2009
Xanodyne Receives Approval From the U.S. Food and Drug Administration for ZIPSOR(TM) (diclofenac potassium) Liquid Filled Capsules
Biopharmaceuticals FDA

HSMN NewsFeed - 27 May 2009
Accumetrics, Inc. Announces European Distribution Channels for France, Austria, Switzerland, Netherlands, Belgium and Luxembourg
Diagnostics Cardiology Distribution

HSMN NewsFeed - 12 May 2009
AstraZeneca Secures Approval for Nexium (esomeprazole) In Peptic Ulcer Bleeding
Biopharmaceuticals Gastroenterology Regulatory

HSMN NewsFeed - 4 May 2009
AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
Biopharmaceuticals

HSMN NewsFeed - 20 Apr 2009
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM)
Biopharmaceuticals

HSMN NewsFeed - 8 Apr 2009
World-First Launch of New Heart Drug
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 23 Mar 2009
FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Mar 2009
Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study
Biopharmaceuticals Cardiology

HSMN NewsFeed - 26 Feb 2009
Gregory J. Tibbitts Appointed Chief Financial Officer at Accumetrics, Inc.
Devices Diagnostics Personnel

HSMN NewsFeed - 23 Feb 2009
European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 3 Feb 2009
Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 30 Jan 2009
Cymbalta(R) Significantly Reduced Osteoarthritis Knee Pain in New Study
Biopharmaceuticals

HSMN NewsFeed - 29 Jan 2009
POZEN Informed by FDA That Endoscopic Gastric Ulcer Incidence Continues to Be an Acceptable Primary Endpoint
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Dec 2008
New Data Shows Zometa(R) Enhances Impact of Chemotherapy on Reducing Breast Tumour Size
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Dec 2008
Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R)
Biopharmaceuticals

HSMN NewsFeed - 28 Nov 2008
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Biopharmaceuticals

HSMN NewsFeed - 4 Nov 2008
Accumetrics, Inc. Appoints William Dippel as Executive Vice President of Operations and R&D
Diagnostics Cardiology Personnel

HSMN NewsFeed - 30 Oct 2008
Timothy I. Still Appointed CEO at Accumetrics
Diagnostics Personnel

HSMN NewsFeed - 13 Oct 2008
12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions
Devices Interventional Cardiology

HSMN NewsFeed - 25 Sep 2008
Anthony Arnerich Appointed Executive Chairman at Accumetrics
Diagnostics Personnel

HSMN NewsFeed - 9 Sep 2008
Brigham and Women's Hospital and Celera Publish Results Demonstrating That Carriers of a Variant of the LPA Gene Have More Than Two-Fold Higher Risk of Major Cardiovascular Events and That This Risk is Eliminated by Aspirin Therapy
Cardiology

HSMN NewsFeed - 3 Sep 2008
New Analysis From HORIZONS-AMI Shows Major Bleeding Has a Significant Impact and Contributes to 30-Day Mortality Following Angioplasty in Severe Heart Attack Patients
Biopharmaceuticals Cardiology

HSMN NewsFeed - 3 Sep 2008
Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel
Biopharmaceuticals Cardiology

HSMN NewsFeed - 3 Sep 2008
New Crossover Study Shows Prasugrel Significantly Reduced Platelet Aggregation in Patients with Acute Coronary Syndromes Compared with Clopidogrel at High Doses
Biopharmaceuticals Cardiology

HSMN NewsFeed - 2 Sep 2008
New Data is Presented on Investigational Oral Anticoagulant Apixaban in Acute Coronary Syndrome Patients
Biopharmaceuticals Cardiology

HSMN NewsFeed - 2 Sep 2008
New Data Shows Anticlotting Medicine, AGGRASTAT(R), Lowers Incidence of Heart Attack, in Patients Who Respond Poorly to Aspirin or Clopidogrel, after Elective Coronary Angioplasty
Biopharmaceuticals Cardiology

HSMN NewsFeed - 26 Aug 2008
ACUITY 1-Year Sub-Analysis Published in Journal of the American College of Cardiology
Biopharmaceuticals Cardiology

HSMN NewsFeed - 25 Aug 2008
Patients Taking Cymbalta(R) Experienced Reduced Chronic Low Back Pain in New Study
Biopharmaceuticals

HSMN NewsFeed - 16 Jun 2008
FDA Approves Cymbalta(R) for the Management of Fibromyalgia
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Jun 2008
Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
Biopharmaceuticals

HSMN NewsFeed - 31 May 2008
Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Premenopausal Women With Early-Stage Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 May 2008
Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Biopharmaceuticals

HSMN NewsFeed - 28 May 2008
The Medicines Company Receives FDA Review Letter for Angiomax Supplemental Filing
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 22 May 2008
Results Published in New England Journal of Medicine Show Angiomax Improved Net Clinical Outcomes and Resulted in Improved Survival Rates in the Most Severe Heart Attack Patients
Biopharmaceuticals Cardiology

HSMN NewsFeed - 15 May 2008
Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
Biopharmaceuticals

HSMN NewsFeed - 8 May 2008
Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 15 Apr 2008
Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Apr 2008
Medicure Comments on Positive AGGRASTAT Results Presented at the American College of Cardiology Annual Scientific Session
Biopharmaceuticals Cardiology

HSMN NewsFeed - 3 Apr 2008
Corgenix Signs Collaboration Agreement With Randox Laboratories to Develop and Market Automated Version of AspirinWorks(R) Test
Diagnostics Cardiology

HSMN NewsFeed - 1 Apr 2008
Lipitor Provided an Unexpectedly Potent Heart Benefit in Patients with Chronic Stable Angina, According to New Study
Biopharmaceuticals Cardiology

HSMN NewsFeed - 31 Mar 2008
Patients Treated with Merck's Investigational Extended-Release Niacin/Laropiprant (CORDAPTIVE(TM)) Reported Significantly Less Flushing Than Patients Treated with Niaspan(TM) in Phase III Study
Biopharmaceuticals Cardiology

HSMN NewsFeed - 29 Mar 2008
Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 29 Mar 2008
Angiomax Demonstrated Improved Outcomes in Acute Heart Attack Patients Undergoing Primary Angioplasty Independent of Individual Risk Factors
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 29 Mar 2008
ISAR-REACT 3 Pits Bivalirudin vs. Unfractionated Heparin in PCI
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 21 Feb 2008
Corgenix Announces Issuance of European Patent for Aspirin Resistance Testing
Diagnostics Cardiology Licensing

HSMN NewsFeed - 15 Feb 2008
Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 31 Jan 2008
Corgenix AspirinWorks(R) Test Now Offered Through Quest Diagnostics
Diagnostics

HSMN NewsFeed - 29 Jan 2008
The Medicines Company's Angiox(R) Receives European Authorization for Expanded Use in Patients with Acute Coronary Syndromes (ACS)
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 21 Jan 2008
Super-Thin Drug-Free Coating 'Hides' Stent as It Unblocks Heart Arteries
Devices Interventional Cardiology

HSMN NewsFeed - 18 Jan 2008
In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
Biopharmaceuticals

HSMN NewsFeed - 7 Jan 2008
Cardica Receives $2 Million Payment From Cook Medical for Successful Completion of Multiple Milestones
Devices Interventional

HSMN NewsFeed - 13 Dec 2007
PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents
Devices Interventional Cardiology

HSMN NewsFeed - 9 Dec 2007
SWOG Phase III Trial Reports REVLIMID(R) (lenalidomide) Plus Dexamethasone Achieves Superior Progression-Free Survival in Newly Diagnosed Multiple Myeloma Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Dec 2007
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results
Biopharmaceuticals Cardiology

HSMN NewsFeed - 30 Nov 2007
FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Nov 2007
Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
Biopharmaceuticals

HSMN NewsFeed - 16 Nov 2007
FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Nov 2007
CV Therapeutics' Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36
Biopharmaceuticals Cardiology Endocrinology

HSMN NewsFeed - 5 Nov 2007
Ranexa(R) Significantly Reduces Incidence of CV Death, MI or Recurrent Ischemia in MERLIN TIMI-36 Patients With Elevated BNP
Biopharmaceuticals Cardiology

HSMN NewsFeed - 4 Nov 2007
Abbott's Investigational SIMCOR(R) Offers Comparable LDL Lowering to Simvastatin and Significantly Raises HDL and Lowers Triglycerides in Phase III Study
Biopharmaceuticals Cardiology

HSMN NewsFeed - 4 Nov 2007
In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 24 Oct 2007
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
Biopharmaceuticals Cardiology

HSMN NewsFeed - 22 Oct 2007
Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome
Devices Interventional Cardiology

HSMN NewsFeed - 22 Oct 2007
Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis
Biopharmaceuticals Pain Management FDA

HSMN NewsFeed - 22 Oct 2007
Schering-Plough Reports Two Phase II Studies of Thrombin Receptor Antagonist (TRA) Build on Findings from Previous Phase II Study
Biopharmaceuticals Cardiology

HSMN NewsFeed - 11 Oct 2007
McNeil Consumer Healthcare is Voluntarily Withdrawing Infants' Cough and Cold Products
Biopharmaceuticals

HSMN NewsFeed - 27 Sep 2007
FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 24 Sep 2007
FDA Accepts sNDA for Expanded Use of Angiomax(R) (bivalirudin)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 19 Sep 2007
FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Sep 2007
GelStat Strengthens Its Management Team With the Addition of William ("Bill") Colucci as Its President
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Sep 2007
REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
Cardiology

HSMN NewsFeed - 4 Sep 2007
Celera to Acquire Berkeley HeartLab, Inc.
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 2 Sep 2007
Angiox(R) (Bivalirudin) Alone Reduced Early Bleeding and Resulted in Similar One-Year Mortality Compared to Heparins Plus GP IIb/IIIa Combination Therapy in ACS Patients Undergoing Angioplasty
Biopharmaceuticals Cardiology

HSMN NewsFeed - 7 Aug 2007
The Medicines Company Submits Angiomax(R) (Bivalirudin) sNDA to Expand Label to Include ACUITY Data
Biopharmaceuticals Cardiology

HSMN NewsFeed - 2 Aug 2007
FDA Issues Second Approvable Letter for Trexima(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Jul 2007
Positive Aggrastat(R) Results Versus Integrilin(R) Featured in American Heart Journal
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 12 Jul 2007
Barr Confirms Patent Challenge of Aggrenox(R)
Biopharmaceuticals Generics

HSMN NewsFeed - 10 Jul 2007
Victory Pharma, Inc. Doubling U.S. Sales Force
Biopharmaceuticals

HSMN NewsFeed - 2 Jul 2007
The Medicines Company Reacquires Angiox(R) (Bivalirudin) Rights in Europe from Nycomed
Biopharmaceuticals Cardiology

HSMN NewsFeed - 19 Jun 2007
Cardica and Cook Medical Enter New Collaboration Agreement to Develop and Commercialize Closure Device for Heart Defects
Devices Cardiology

HSMN NewsFeed - 8 Jun 2007
Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
Biopharmaceuticals Neurology

HSMN NewsFeed - 5 Jun 2007
Health Canada's approval of an expanded indication for PLAVIX(R) (clopidogrel bisulfate) now offers protection from all types of heart attacks
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 4 Jun 2007
Corgenix AspirinWorks(R) Test Kit Cleared by FDA
Diagnostics Cardiology FDA

HSMN NewsFeed - 22 May 2007
XTENT Announces Promising Six-Month Custom II Trial Data Presented at EuroPCR Meeting
Devices Interventional Cardiology

HSMN NewsFeed - 22 May 2007
ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
Devices Interventional Cardiology

HSMN NewsFeed - 18 May 2007
FDA Approves Lovenox(R) (Enoxaparin Sodium Injection) for the Most Severe Type of Heart Attack
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 17 May 2007
Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many Aspects of Daily Life
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 16 May 2007
FDA Advisory Committee Recommends Expanded Use of FluMist(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 2 May 2007
Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 May 2007
Trexima(TM) (Sumatriptan/Naproxen Sodium) Provided Relief of Both Traditional and Non-traditional Migraine Symptoms
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 May 2007
FDA Approves FRAGMIN(R) as First Low-Molecular-Weight Heparin for Extended Treatment to Reduce the Recurrence of Blood Clots in Patients with Cancer
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Apr 2007
New Indication for SINGULAIR(R) (montelukast sodium) Approved to Prevent Exercise-induced Bronchoconstriction
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Apr 2007
Journal of the American Medical Association Publishes MERLIN TIMI-36 Results
Biopharmaceuticals Cardiology

HSMN NewsFeed - 18 Apr 2007
Schering-Plough Announces Initiation of Two Phase III Clinical Trials for Novel Selective Antiplatelet Therapy (TRA-SCH 530348)
Biopharmaceuticals Cardiology

HSMN NewsFeed - 26 Mar 2007
ACUITY One-Year Findings Meet All Primary Endpoints in Favor of Angiomax(R) (Bivalirudin) Alone Treatment Group
Biopharmaceuticals Cardiology

HSMN NewsFeed - 24 Mar 2007
Schering-Plough's Novel Oral Thrombin Receptor Antagonist Meets Primary Endpoint in Phase II Trial
Biopharmaceuticals Cardiology

HSMN NewsFeed - 13 Mar 2007
PARI's Hydrate Receives FDA 510k Clearance
Devices FDA

HSMN NewsFeed - 13 Mar 2007
Introducing New ALEVE(R) Liquid Gels
Biopharmaceuticals

HSMN NewsFeed - 5 Mar 2007
Corgenix Signs Licensing Agreement and Gains Full Rights to AspirinWorks(R) Aspirin Response Test
Diagnostics

HSMN NewsFeed - 27 Feb 2007
American Heart Association Scientific Statement: AHA Statement Recommends Doctors Change Approach to Prescribing Pain Relievers for Patients With or at Risk for Heart Disease
Biopharmaceuticals Cardiology

HSMN NewsFeed - 27 Feb 2007
Aspirin Significantly Reduces Esophageal-Cancer Risk in People With Most- Aggressive Form of Barrett's Esophagus
Biopharmaceuticals Oncology

HSMN NewsFeed - 24 Jan 2007
Zylera Pharmaceuticals Announces Availability of RELAMINE for the Treatment of Osteoarthritis
Biopharmaceuticals

HSMN NewsFeed - 8 Jan 2007
FDA Approves MedImmune's Refrigerated Formulation of FluMist(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Dec 2006
Vascular Solutions Announces Approval of 'Pocket Protector' Indication for D-Stat Flowable Hemostat
Devices Cardiology FDA

HSMN NewsFeed - 5 Dec 2006
American Heart Association Statement on Use of Drug-Eluting Coronary Stents
Devices Interventional Cardiology

HSMN NewsFeed - 22 Nov 2006
The New England Journal of Medicine Publishes Angiomax(R) (Bivalirudin) ACUITY Trial Results
Biopharmaceuticals Cardiology

HSMN NewsFeed - 13 Nov 2006
Large Outcomes Study Showed Merck's ARCOXIA(R) (etoricoxib) had Similar Rates of Cardiovascular Thrombotic Events Compared to Diclofenac, the Most Prescribed Traditional NSAID Worldwide
Biopharmaceuticals

HSMN NewsFeed - 13 Nov 2006
Volcano Announces Clinical Review of Key Presentations From TCT 2006
Devices Interventional Cardiology

HSMN NewsFeed - 9 Nov 2006
POZEN Submits Full Response to FDA Approvable Letter For Trexima(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Oct 2006
Auriga Laboratories Enters Into Co-Marketing Agreement With Pharmelle LLC for Sale of Company's Aquoral Product
Biopharmaceuticals Urology

HSMN NewsFeed - 26 Oct 2006
Lipicard's Platrol(R) - First Safe, Sustained Release Antiplatelet Drug Developed Through a Novel Platform Technology
Biopharmaceuticals Cardiology

HSMN NewsFeed - 23 Oct 2006
New Study Shows Prasugrel Achieves Faster Onset and Higher Levels of Platelet Inhibition than Clopidogrel at Approved or Higher Doses
Biopharmaceuticals Cardiology

HSMN NewsFeed - 15 Oct 2006
Cyberkinetics' BrainGate System Enables Thought-Driven Communication Device and Wheelchair Control for First Stroke Participant in Pilot Clinical Trial
Devices Neurology

HSMN NewsFeed - 14 Oct 2006
Cyberkinetics' BrainGate System Enables Thought-Driven Computer Control for First ALS Patient in Pilot Clinical Trial
Devices Neurology

HSMN NewsFeed - 20 Sep 2006
New Analysis Shows Patients Who Treat Their Migraine Pain Early With Trexima(TM) (Sumatriptan Succinate/Naproxen Sodium) Have Higher Sustained Pain-Free Rates Than Those Who Treat Late
Biopharmaceuticals

HSMN NewsFeed - 20 Sep 2006
New Data Show Consistent Efficacy and Tolerability of Trexima(TM) (Sumatriptan Succinate/Naproxen Sodium) Across Multiple Migraine Attacks
Biopharmaceuticals

HSMN NewsFeed - 20 Sep 2006
New Data Show Peak Concentration of Sumatriptan Occurred Earlier With Trexima(TM) (Sumatriptan Succinate/Naproxen Sodium) Compared to Imitrex(R) (Sumatriptan Succinate)
Biopharmaceuticals

HSMN NewsFeed - 14 Sep 2006
ACTOS(R) (pioglitazone HCl) Demonstrates Significant Improvements in Cardiovascular Outcomes for High-Risk Patients With Type 2 Diabetes
Biopharmaceuticals Endocrinology Cardiology

HSMN NewsFeed - 12 Sep 2006
Javelin Pharmaceuticals, Inc. To Present Final Analysis of Phase 2b Study Results of Dyloject(TM) at Prestigious European Pain Conference - September 14, 2006
Biopharmaceuticals

HSMN NewsFeed - 7 Sep 2006
European commission expands indication for PLAVIX® (clopidogrel bisulfate) offering new option for patients with most severe type of heart attack
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 7 Sep 2006
Quest Diagnostics Acquires Maker of InSure(R) Colorectal Cancer Screening Test
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 18 Jul 2006
MedImmune Receives Complete Response Letter From FDA for New Formulation of FluMist(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Jul 2006
Kos Submits Supplemental New Drug Application To FDA For New Niaspan(R) CF Range of Products
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 6 Jul 2006
Corgenix Launches Diagnostic Test for Aspirin Effectiveness
Diagnostics

HSMN NewsFeed - 6 Jul 2006
MedImmune Receives FDA Approval to Use Reverse Genetics Technology for FluMist(R) Vaccine Production
Biopharmaceuticals FDA

HSMN NewsFeed - 25 May 2006
Thalomid(R) sNDA Granted FDA Approval For Treatment of Newly Diagnosed Multiple Myeloma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 17 May 2006
New Stroke Guidelines Underscore Importance of Aspirin for Women
Biopharmaceuticals Neurology

HSMN NewsFeed - 11 May 2006
Conor Medsystems Initiates RAPID Clinical Study for First Pimecrolimus Drug-Eluting Stent
Devices Interventional Cardiology

Return to NewsFeed

Additional items found! 188

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 188 additional stories matching:
aspirin
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.